首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma
【24h】

Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma

机译:表现出CD44和细胞角蛋白5(尿检干细胞/基础细胞标志物)的弥漫性免疫反应性的扁平管状肿瘤瘤:与肌肉侵袭性尿路上皮癌的膀胱内瘤形成的一种变种

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Immunoreactivity for CD44 and cytokeratin (CK)5 (urothelial stem/basal cell markers) are decreased/negative in the common type of intraurothelial neoplasia including urothelial carcinomas (UC) in situ. Recent studies also reveal that a majority of muscle-invasive UC are basal-like UC with large areas of positive CD44/CK5 immunoreactivity. In addition, approximately 80% of muscle-invasive UC develop de novo as nonpapillary invasive UC. In this study, we investigate the CD44/CK5 immunoreactivity of the flat intraurothelial neoplasia (FIUN) associated with nonpapillary invasive UC. Materials and Methods: Consecutive cases of nonpapillary UC were submitted for immunostaining. Immunostaining for CK5/ CD44 was scored as high for staining of >25% thickness of urothelium and low for lesser immunoreactivity. Results: In total, 109 consecutive cases were grouped into: in situ UC [carcinoma in situ (CIS)] (n = 11), pT1 (n = 14), and pT2-4 (n = 84) with surface urothelium available for study. Forty-four cases including CIS (n = 9), pT1 (n = 12), and pT2-4 (n = 23) showed FIUN with low/negative CD44/CK5 reactivity; 40 cases showed strong CK20 reactivity. Sixty-two cases including CIS (n = 2), pT1 (n = 2), and pT2-4 (n = 58) showed extensive FIUN exhibiting high CD44/CK5 reactivity; 30 cases showed reactive CK20. FIUN lesions with high CD44/CK5 reactivity scores were associated with mild (urothelial dysplasia) to moderate atypia (CIS) and were rarely preceded by papillary UC. Most invasive UC associated with FIUN with high CD44/CK5 reactivity also exhibited extensive CD44/CK5 reactivity. The remaining 3 cases showed only reactive urothelium. Of interest, 4 cases with FIUN showed negative CD44/CK5/CK20 reactivity. Conclusions: Existence of CD44/CK5-immunoreactive (or basal-like) FIUN is consistent with the recent distinction of basal and luminal subtypes of UC. This type of FIUN is often associated with UC with progression to high-stage disease not preceded by recurrent papillary UC.
机译:背景:CD44和细胞角蛋白(CK)5(尿检茎/基础细胞标记物)的免疫反应性在常见类型的内颈内瘤中降低/阴性,包括尿李素癌(UC)原位。最近的研究还揭示了大多数肌肉侵袭性UC是基础样UC,具有大面积的阳性CD44 / CK5免疫反应性。此外,大约80%的肌肉侵袭性UC开发De Novo作为非帕帕皮脂侵入式UC。在这项研究中,我们研究了与非蛋白侵袭性UC相关的扁平管内瘤瘤(FIUN)的CD44 / CK5免疫反应性。材料和方法:提交了连续的非蛋白酶UC的案例进行免疫抑制。对于CK5 / CD44的免疫染色较高,用于染色的尿素厚度> 25%,对于较小的免疫反应性为低。结果:总共109例,将109例分组为:原位UC [原位(顺式)](n = 11),Pt1(n = 14)和pt2-4(n = 84),具有表面尿液鞘学习。包括顺式(n = 9),pt1(n = 12)和pt2-4(n = 23),包括低/阴性CD44 / CK5反应性的FIUN; 40例表现出强烈的CK20反应性。六十二个病例包括顺式(n = 2),pt1(n = 2)和pt2-4(n = 58)显示出广泛的FIUN表现出高CD44 / CK5反应性; 30例显示反应性CK20。具有高CD44 / CK5反应性分数的FIUN病变与轻度(尿路上皮发育不良)与中度Atypia(CIS)有关,并且很少被乳头状UC先前。具有高CD44 / CK5反应性的侵入性UC的大多数侵入性UC也表现出广泛的CD44 / CK5反应性。其余3例仅显示反应性尿路升性。感兴趣的,4例FIUN显示阴性CD44 / CK5 / CK20反应性。结论:CD44 / CK5 - 免疫反应性(或基础状)FIUN的存在与最近UC的基础和腔胎型的近期区别一致。这种类型的FIUN通常与UC相关,其前期未经复制乳头UC的高阶疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号